Clinical variables such as tumor size, estrogen, progesterone receptor positivity, HER2, and tumor grade, as well as some metabolic variables such as SUVpeak, SUVmean, and SUVmax, had a statistically significant association with the target variable (metabolic response). This evidence concerns the gene ERBB2 and neoplasm.